We are live on ! Find out more
SG

StoneX Group Portfolio holdings

AUM $1.86B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+21.3%
3 Year Est. Return
+67.54%
5 Year Est. Return
+78.7%
10 Year Est. Return
–
AUM
$696M
AUM Growth
+$21.3M
Cap. Flow
+$32.4M
Cap. Flow %
4.65%
Top 10 Hldgs %
25.5%
Holding
522
New
50
Increased
243
Reduced
154
Closed
55

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$9.46M
2
ORAN
Orange
ORAN
+$6.91M
3
GINN icon
Goldman Sachs Innovate Equity ETF
GINN
+$6.08M
4
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$4.08M
5
NVO
Novo Nordisk
NVO
+$4.04M

Top Sells

Rank Stock Value
1
SNN icon
Smith & Nephew
SNN
+$11.7M
2
EWL icon
iShares MSCI Switzerland ETF
EWL
+$7.29M
3
FTSM icon
First Trust Enhanced Short Maturity ETF
FTSM
+$3.54M
4
RELX icon
RELX
RELX
+$2.86M
5
CAT icon
Caterpillar
CAT
+$2.61M

Sector Composition

Rank Sector Weight
1 Technology 7.02%
2 Healthcare 4.68%
3 Consumer Discretionary 3.2%
4 Communication Services 2.97%
5 Financials 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USO icon
451
United States Oil Fund
USO
$2.45B
$202K 0.03%
+3,840
New +$188K
OLED icon
452
Universal Display
OLED
$3.71B
$201K 0.03%
1,173
– –
PSLV icon
453
Sprott Physical Silver Trust
PSLV
$11.9B
$192K 0.03%
25,042
-11,135
-31% -$94.7K
AMYT
454
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$187K 0.03%
+15,510
New +$175K
TAK icon
455
Takeda Pharmaceutical
TAK
$55.1B
$164K 0.02%
+10,022
New +$168K
FXN icon
456
First Trust Energy AlphaDEX Fund
FXN
$398M
$144K 0.02%
12,547
+1,778
+17% +$18.8K
SMFG icon
457
Sumitomo Mitsui Financial
SMFG
$166B
$141K 0.02%
+20,170
New +$140K
GNPX icon
458
Genprex
GNPX
$3.94M
$94K 0.01%
1
– –
BW icon
459
Babcock & Wilcox
BW
$1.43B
$87K 0.01%
13,500
– –
AXDX
460
DELISTED
Accelerate Diagnostics
AXDX
$63K 0.01%
1,074
-100
-9% -$6.52K
THER
461
DELISTED
THERATECHNOLOGIES INC COM
THER
$53K 0.01%
14,000
– –
BTCY
462
DELISTED
Biotricity, Inc. Common Stock
BTCY
$32K ﹤0.01%
+1,827
New +$34.3K
SPKBW
463
DELISTED
Silver Spike Acquisition Corp II Warrant
SPKBW
$14K ﹤0.01%
+12,500
New +$15K
NGD
464
DELISTED
New Gold Inc
NGD
$11K ﹤0.01%
+10,200
New +$14K
GSAQW
465
DELISTED
Global Synergy Acquisition Corp. Warrant
GSAQW
$11K ﹤0.01%
+19,900
New +$13.9K
ZOM
466
DELISTED
Zomedica Corp.
ZOM
$10K ﹤0.01%
20,000
– –
ADM icon
467
Archer Daniels Midland
ADM
$41.4B
– –
-3,605
Closed -$218K
AMC icon
468
AMC Entertainment Holdings
AMC
$2.03B
– –
-353
Closed -$200K
AMCR icon
469
Amcor
AMCR
$20.6B
– –
-4,326
Closed -$248K
AUPH icon
470
Aurinia Pharmaceuticals
AUPH
$1.97B
– –
-10,650
Closed -$138K
AZN icon
471
AstraZeneca
AZN
$263B
– –
-17,503
Closed -$2.1M
BABA icon
472
Alibaba
BABA
$269B
– –
-1,093
Closed -$248K
BBVA icon
473
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
– –
-15,087
Closed -$94K
BDRX
474
Biodexa Pharmaceuticals
BDRX
$1.49M
– –
0
– -$68K
BEAM icon
475
Beam Therapeutics
BEAM
$2.58B
– –
-1,992
Closed -$256K
17 18
19
20 21

Similar funds

CFA
Capstone Financial Advisors Downers Grove, Illinois $1.86B AUM 15.98% 1-Year Est. Return
OFG
Oxford Financial Group Carmel, Indiana $1.86B AUM 19.25% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
GRA
Goehring & Rozencwajg Associates New York $1.86B AUM 130.26% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
EAM
Evanson Asset Management Carmel, California $1.86B AUM 25.39% 1-Year Est. Return

StoneX Group's Q3 2021 Portfolio in Review

As of Q3 2021, StoneX Group held 522 positions worth $696M, up 3.2% from $674M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

StoneX Group deployed $32.4M of net new capital in Q3 2021, opening 50 new positions and adding to 243 existing holdings. Its largest new stake was Novartis: 105,169 shares worth $8.6M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was First Trust Enhanced Short Maturity ETF, an estimated $3.54M trimmed.

  • StoneX Group's largest Q3 2021 buy was Novartis: 105,169 shares worth $8.6M.
  • StoneX Group added most to Novo Nordisk in Q3 2021, an estimated $4.04M increase.
  • StoneX Group's biggest Q3 2021 reduction was First Trust Enhanced Short Maturity ETF, cutting an estimated $3.54M.
  • StoneX Group fully exited Smith & Nephew in Q3 2021, selling an estimated $11.7M.
  • StoneX Group's ten largest holdings make up 25% of its $696M portfolio in Q3 2021.
  • StoneX Group opened 50 new positions and closed 55 in Q3 2021.
  • StoneX Group's portfolio value rose 3.2% quarter-over-quarter to $696M.

Based on StoneX Group's 13F filing for Q3 2021, filed 20 Oct 2021.